NCT04965259 - Early Detection of Hepatocellular Carcinoma in a High-risk Prospective Cohort (ELEGANCE) | Biotech Hunter

Enrollment

2,002

Participants

Timeline

Start Date

April 15, 2021

Primary Completion Date

March 11, 2025

Study Completion Date

December 21, 2026

Conditions

Liver Diseases

Trial Locations (14)

119228

National University Hospital, Singapore

150163

SingHealth Polyclinics - Bukit Merah, Singapore

168583

National Cancer Center Singapore, Singapore

168937

SingHealth Polyclinics - Outram, Singapore

169608

Singapore General Hospital, Singapore

308433

Tan Tock Seng Hospital, Singapore

440080

SingHealth Polyclinics - Marine Parade, Singapore

469662

SingHealth Polyclinics - Bedok, Singapore

519457

SingHealth Polyclinics - Pasir Ris, Singapore

529203

SingHealth Polyclinics - Tampines, Singapore

529889

Changi General Hospital, Singapore

544886

Sengkang General Hospital, Singapore

545025

SingHealth Polyclinics - Sengkang, Singapore

820681

SingHealth Polyclinics - Punggol, Singapore

All Listed Sponsors

collaborator

Duke-NUS Graduate Medical School

OTHER

collaborator

Singapore Phenome Centre

UNKNOWN

collaborator

Nanyang Technological University

OTHER

collaborator

MiRXES Pte Ltd

INDUSTRY

collaborator

Perspectum Asia Pte Ltd

UNKNOWN

collaborator

Asian Microbiome Library Pte Ltd

UNKNOWN

lead

National Cancer Centre, Singapore

OTHER